A short course of methylprednisolone immunosuppression inhibits both rejection and spontaneous acceptance of rat liver allografts

被引:57
作者
Wang, CM
Sun, JH
Sheil, AGR
McCaughan, GW
Bishop, GA
机构
[1] Univ Sydney, Royal Prince Alfred Hosp, Australian Natl Liver Transplantat Unit, Dept Transplantat Surg, Sydney, NSW 2006, Australia
[2] Univ Sydney, Sydney, NSW 2006, Australia
[3] Royal Prince Alfred Hosp, Centenary Inst, AW Morrow Liver Immunobiol Lab, Camperdown, NSW 2050, Australia
关键词
D O I
10.1097/00007890-200107150-00011
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 [免疫学];
摘要
Background The effects of immunosuppressive drugs on transplant tolerance have not been extensively studied, although their effect on rejection is well established. Methods. We examined the effects of a short course of treatment with the immunosuppressive drug methylprednisolone (MP) on the survival of PVG; liver allografts in Dark Agouti (DA) recipients that accepted the livers and in Lewis recipients that rejected the livers. Infiltration of liver allografts was examined by immunohistochemical staining of liver sections, and apoptosis was measured by terminal deoxynucleotide transferase-mediated dUTP nick end labeling. Results. A S-day course of MP (days 0 to 4) led to rejection of four of six livers (mean survival time [MST] 99 days) in DA recipients compared with longterm survival (MST >100 days) in untreated animals. Delayed administration of MP (days 3 to 7) exacerbated rejection in DA recipients, and all eight animals rejected the graft (MST 68.5 days). Treatment of Lewis recipients with MP did not significantly prolong survival when administered from days 0 to 4 (MST 13 days), although delay of administration improved the outcome. Treatment from days 3 to 7 resulted in an MST of 21 days, whereas treatment from days 7 to 11 resulted in an MST of 41.5 days. MP treatment from day 3 to day 7 reduced T cells and interleukin 2 receptor-expressing cells but increased the numbers of apoptotic cells infiltrating both DA and Lewis strain allografts. Conclusions. These results show that immunosuppression with MP inhibits both spontaneous tolerance and rejection of liver allografts in a rat model and question the efficacy of administering MP to all liver allograft recipients from the time of transplantation.
引用
收藏
页码:44 / 51
页数:8
相关论文
共 26 条
[1]
ARYA SK, 1984, J IMMUNOL, V133, P273
[2]
Bingisser RM, 1998, J IMMUNOL, V160, P5729
[3]
Bishop GA, 1996, J IMMUNOL, V156, P4925
[4]
High-dose/activation-associated tolerance - A mechanism for allograft tolerance [J].
Bishop, GA ;
Sun, JH ;
Sheil, AGR ;
McCaughan, GW .
TRANSPLANTATION, 1997, 64 (10) :1377-1382
[5]
INDUCTION OF IMMUNOLOGICAL TOLERANCE BY PORCINE LIVER ALLOGRAFTS [J].
CALNE, RY ;
SELLS, RA ;
PENA, JR ;
DAVIS, DR ;
MILLARD, PR ;
HERBERTSON, BM ;
BINNS, RM ;
DAVIES, DAL .
NATURE, 1969, 223 (5205) :472-+
[6]
ENHANCED RISK OF STEROID-RESISTANT ACUTE REJECTION FOLLOWING PRETRANSPLANT STEROID-THERAPY IN LIVER GRAFT RECIPIENTS [J].
CONTI, F ;
DOUSSET, B ;
ARCHAMBEAU, D ;
LOUVEL, A ;
HOUSSIN, D ;
CALMUS, Y .
TRANSPLANTATION, 1995, 60 (10) :1104-1108
[7]
Excellent long-term graft survival in low risk, primary renal allografts treated with prednisolone-avoidance immunosuppression [J].
Elias, TJ ;
Bannister, KM ;
Clarkson, AR ;
Russ, GR ;
Mathew, TH ;
Barratt, LJ ;
Faull, RJ .
CLINICAL TRANSPLANTATION, 2000, 14 (02) :157-161
[8]
IDENTIFICATION OF PROGRAMMED CELL-DEATH INSITU VIA SPECIFIC LABELING OF NUCLEAR-DNA FRAGMENTATION [J].
GAVRIELI, Y ;
SHERMAN, Y ;
BENSASSON, SA .
JOURNAL OF CELL BIOLOGY, 1992, 119 (03) :493-501
[9]
KAMADA N, 1983, SURGERY, V93, P64
[10]
Treatment with humanized monoclonal antibody against CD154 prevents acute renal allograft rejection in nonhuman primates [J].
Kirk, AD ;
Burkly, LC ;
Batty, DS ;
Baumgartner, RE ;
Berning, JD ;
Buchanan, K ;
Fechner, JH ;
Germond, RL ;
Kampen, RL ;
Patterson, NB ;
Swanson, SJ ;
Tadaki, DK ;
TenHoor, CN ;
White, L ;
Knechtle, SJ ;
Harlan, DM .
NATURE MEDICINE, 1999, 5 (06) :686-693